BMI 18.5–30, n (%) 2,911 (55.1) 1,386 (53.8) 253 (36.7) 1,229 (55.0) 189 (56.6) BMI >30, n (%) 1,224 (23.2) 864 (33.5) 196 (28.4) 141 (6.3) 98 (29.3) Missing, n (%) 1,123 (21.2) 321 (12.5) 238 (34.5) 819 (36.7) 45 (13.5) First available creatinine clearance (mL/min), n (%) <15 7 (0.1) 24 (0.9) 0 (0) 15 (0.7) 1 (0.3) 15–29 60 (1.1) 33 (1.3) 9 (1.3) 55 (2.5) 9 (2.7) 30–49 447 (8.5) 241 (9.4) 43 (6.2) 296 (13.3) 34 (10.2) 50–80 1,905 (36.0) 801 (31.1) 151 (21.9) 535 (24.0) 86 (25.7) >80 1,090 (20.6) 749 (29.1) 171 (24.8) 256 (11.5) 54 (16.2) Missing 1,778 (33.6) 729 (28.3) 316 (45.8) 1,076 (48.2) 150 (44.9) Preexisting comorbidities, n (%) Hypertension 3,733 (70.6) 2,288 (88.8) 532 (77.1) 1,639 (73.4) 284 (85.0) Diabetes mellitus 1,015 (19.2) 524 (20.3) 288 (41.7) 589 (26.4) 68 (20.4) stroke/TIA/non-CNS SE 867 (16.4) 627 (24.3) 90 (13.0) 734 (32.9) 54 (16.2)
BMI 18.5–30, n (%) BMI >30, n (%) Missing, n (%) 2,911 (55.1) 1,224 (23.2) 1,123 (21.2) 1,386 (53.8) 864 (33.5) 321 (12.5) 253 (36.7) 196 (28.4) 238 (34.5) 1,229 (55.0) 141 (6.3) 819 (36.7) 189 (56.6) 98 (29.3) 45 (13.5) First available creatinine clearance (mL/min), n (%) <15 15–29 30–49 50–80 >80 Missing 7 (0.1) 60 (1.1) 447 (8.5) 1,905 (36.0) 1,090 (20.6) 1,778 (33.6) 24 (0.9) 33 (1.3) 241 (9.4) 801 (31.1) 749 (29.1) 729 (28.3) 0 (0) 9 (1.3) 43 (6.2) 151 (21.9) 171 (24.8) 316 (45.8) 15 (0.7) 55 (2.5) 296 (13.3) 535 (24.0) 256 (11.5) 1,076 (48.2) 1 (0.3) 9 (2.7) 34 (10.2) 86 (25.7) 54 (16.2) 150 (44.9) Preexisting comorbidities, n (%) Hypertension Diabetes mellitus stroke/TIA/non-CNS SE 3,733 (70.6) 1,015 (19.2) 867 (16.4) 2,288 (88.8) 524 (20.3) 627 (24.3) 532 (77.1) 288 (41.7) 90 (13.0) 1,639 (73.4) 589 (26.4) 734 (32.9) 284 (85.0) 68 (20.4) 54 (16.2)
1-s2.0-S0735109718347958-mmc1.docx